Objective: Influenza, even though it can affect people of any age, is usually a self-limiting infection. However, it is an important and remarkable disease due to the reasons such as leading to epidemics and pandemics, disrupting work and school attendance, and causing serious morbidity and mortality, especially in risk groups. Influenza may cause social and economic losses as well as fatal complications especially in the risk groups such as pregnant women. On the basis of this observation, our study aimed at retrospectively reviewing the answers of the pregnant women, who have visited our clinic, to the questions we routinely asked them as a component of their history of immunization, about their flu vaccination status and, if they have not been vaccinated, about the reason of this choice. Method: The pregnant women in the 18-50 age range, who have visited the Hospital of Zonguldak Bülent Ecevit University Medical School between 1st September 2019 and 1st February 2020, regardless of any other criterion, were asked about their educational status and whether they have had a flu vaccine during pregnancy. Those who have not been vaccinated were asked about the reason for not receiving the vaccine; whether they did not know about the vaccine, whether they thought that they did not need it or that the vaccine might do harm to their babies. Thus, the information about the 267 pregnant women in total was recorded. Findings: A total of 267 pregnant women, of whom 216 (80,9%) were under 35 years of age, and 51 (19,1%) aged 35 and over were included in our study and the mean age of the pregnant women was found to be 29,03 ± 6,11. Of the pregnant women six (2,2%) have received the flu vaccine and 261 (97,8%) have not been vaccinated against flu. Of the 261 pregnant women, 164 (62,8%), 30 (11,5%) and 67 (25,7%) answered "I did not know", "I did not need" and "It might cause harm", respectively, as a reason for not having a flu vaccine. There was no statistically significant difference between the educational status and age groups in terms of being vaccinated (p = 1,000). Accordingly, it is noteworthy that pregnant women, regardless of their age and educational status, have not been informed sufficiently about the influenza vaccine. Conclusion: In spite of the proven effectiveness of the vaccine, the seasonal influenza vaccination rates are still low around the world and in our country. In fact, when the literature is examined, it is striking that there are similar situations in different regions of the world. The reasons why the influenza vaccination rate among pregnant women was found to be as low as 2,2% in our study have common aspects with those in similar studies. The majority of pregnant women have not been informed that they should receive the flu vaccine. In this regard, family physicians and physicians providing secondary healthcare have a great duty. In the light of this fact, pregnant women should definitely be informed at pregnancy schools and family health centers about the necessity for vaccination.
Objective: To investigate the efficacy of oral 10 mg Hyoscine N Butyl Bromur (HBB) on pain perception of the patients who underwent endometrial biopsy with Pipelle. Material and Methods: The charts of the patients who were 18-49 years and underwent endometrial biopsy with Pipelle for evaluation of abnormal uterine bleeding at Zonguldak Bülent Ecevit University, between September 2018 and September 2019 were retrospectively evaluated. 48 patients were seperated as HBB Group who used oral 10 mg HBB 30 minutes before endometrial biopsy and 56 patients as Control Group who did not used any pain relief medication before endometrial biopsy. Results: There were no statistically significant difference between two groups in age, BMI, parity, number of vaginal and cesarean births, nulliparity, multipartiy, and menopausal status. On the other hand, VAS (0) scores which were recorded immediately after endometrial biopsy and VAS (30) scores which were recorded 30 minutes after endometrial biopsy of the patients of the HBB Group were lower than the Control Group
Kliniği'nde serklaj yapılmış olan hastaların medikal bilgileri retrospektif olarak incelendi. Servikal yetmezlik ile ilişkili bir veya daha fazla ikinci trimester gebelik kaybı hikayesi bulunan ya da servikal yetmezlik nedeniyle daha önce serklaj yapılmış olan hastalar proflaktik serklaj grubu olarak, ikinci trimesterde ağrısız servikal dilatasyon ve/veya membranların vajene prolabe olduğu saptanarak serklaj yapılan olgular ise acil serklaj grubu olarak ayrıldı. Gruplar arasında gebelik süresince gelişen komplikasyonlar, perinatal sonuçlar ve inflamatuar belirteçlerden lökosit (WBC), periferik kan nötrofil-lenfosit oranı (NLR) ve trombosit -lenfosit oranı (PLR) karşılaştırıldı.Bulgular: Yirmi yedi olgudan oluşan proflaktik serklaj grubunda canlı doğum oranı %96,6 iken, 16 olgudan oluşan acil serklaj grubunda canlı doğum oranı yine oldukça yüksek bir oran olan %81,3 olarak saptandı. Proflaktik serklaj ve acil serklaj yapılan hastaların canlı doğum oranı, doğum haftası, preterm doğum oranı ve doğum kilosu her iki grupta da benzerdi (p=0,137; p=0,179; p= 0,085; p=0,602). Acil serklaj yapılan olguların servikal dilatasyonları 1-4 cm arasında değişmekteydi. Beş olguda servikal dilatasyon ≥3 cm ve membranlar prolabe idi, bu olguların sadece biri (%20) canlı term doğumla sonuçlandı. Acil serklaj grubunda lökosit (WBC) sayısı proflaktik serklaj grubundan daha yüksek bulundu (p=0,037). Buna karşılık NLR, PLR, nötrofil, lenfosit ve trombosit sayıları ise her iki grupta farksız saptandı. Tüm olgular içinde preterm doğumlar ile term doğumlar arasında yapılan karşılaştırmada ise WBC, NLR ve PLR değerleri açısından fark saptanmadı. Sonuç: Acil serklaj operasyonunun perinatal sonuçları proflaktik serklaj operasyonu ile benzer ve her iki grupta da canlı doğum ve term doğum oranları yüksek saptanmıştır. Bununla beraber acil serklaj yapılan grupta servikal dilatasyonun ≥3 cm olduğu olgularda ise neonatal mortalite, abortus ve preterm prematür membrane rüptürü oranı yüksektir. Bu bulgular özellikle acil serklaj yapılacak hastaların seçiminde dikkatli olmak gerektiğini göstermektedir.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.